why choose us

First received: July 23, 2023

Clinical Trial: Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: T Lymphoblastic Leukemia/Lymphoma

Study Type: INTERVENTIONAL


Official Title: A Phase ll, Multi-center, Single-arm Clinical Study of Low-dose Chidamide Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for T-cell Acute Lymphoblastic Leukemia or T-cell

Brief Summary: Clinical Study on the Safety and Effectiveness of low-dose chidamide maintenance therapy after allogeneic hematopoietic stem cell transplantation for T-cell acute lymphoblastic leukemia or T-cell lymphomas.

Read more